CHOP researchers have taken a significant step forward in developing gene therapy against Batten disease, a fatal neurodegenerative disorder that strikes children.

The Children’s Hospital of Philadelphia’s (CHOP) Division of Orthopedics was recently named one of Becker’s Hospital Review’s 100 Hospitals with Great Orthopedic Programs for 2015.

CHOP pediatric oncology researchers have pinpointed a crucial change in a single DNA “letter” that predisposes children to an aggressive form of neuroblastoma.

The mere mention of head lice makes everyone itchy but there's no reason to panic if your child gets them - they don't carry disease and are easily treated.

By identifying details of the abnormal biological signals behind a high-risk form of the childhood cancer neuroblastoma, researchers aim to develop more effective treatments.

The Four Seasons Parkway Run & Walk raised over $1 million and proceeds support research and survivorship programs at CHOP’s Cancer Center.

CHOP celebrated the grand opening of a 44,000-square-foot Specialty Care and Ambulatory Surgery Center in Glen Mills, Pa. that will bring additional services to local families.

On Oct. 4, CHOP's Center for Fetal Diagnosis and Treatment hosted a reunion at the Cleveland Botanical Gardens for families across the Midwest who traveled to CHOP for fetal surgery or specialized care immediately after birth.

A new study in animals shows very dynamic ways in which the immune system responds to influenza virus, and may offer insights for designing better vaccines.

CHOP researchers have debunked the claim that childhood vaccinations may cause young children to have retinal hemorrhage (bleeding in the eye’s retina).